Cardinal Health, Inc. (NYSE:CAH) Given Consensus Rating of “Moderate Buy” by Brokerages

Cardinal Health, Inc. (NYSE:CAH) has received an average recommendation of “Moderate Buy” from the sixteen analysts that are covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $209.00.

A number of equities research analysts have recently commented on CAH shares. Argus increased their target price on Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research note on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research report on Tuesday, November 18th. Evercore ISI raised their price objective on shares of Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. Barclays initiated coverage on shares of Cardinal Health in a research note on Monday, December 8th. They issued an “overweight” rating and a $243.00 target price on the stock. Finally, TD Cowen raised their price target on shares of Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, November 3rd.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $208.25 on Wednesday. The company has a 50 day simple moving average of $202.72 and a two-hundred day simple moving average of $172.39. Cardinal Health has a fifty-two week low of $119.11 and a fifty-two week high of $214.93. The company has a market capitalization of $49.48 billion, a price-to-earnings ratio of 31.41, a P/E/G ratio of 1.50 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The company had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter in the prior year, the business posted $1.88 EPS. The firm’s quarterly revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, analysts forecast that Cardinal Health will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s payout ratio is currently 30.77%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CAH. SJS Investment Consulting Inc. increased its stake in Cardinal Health by 1,363.6% in the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after acquiring an additional 150 shares during the last quarter. Atlantic Edge Private Wealth Management LLC lifted its position in Cardinal Health by 75.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after purchasing an additional 75 shares during the last quarter. JPL Wealth Management LLC purchased a new position in shares of Cardinal Health in the 3rd quarter worth $31,000. Turning Point Benefit Group Inc. bought a new stake in shares of Cardinal Health in the 3rd quarter worth about $31,000. Finally, Vermillion & White Wealth Management Group LLC raised its position in shares of Cardinal Health by 55.0% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after buying an additional 71 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.